Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehealth for private practices, occupational health and case management, healthcare systems and hospitals, and sports. It also offers Physiapp, a mobile application that allows physiotherapists to deliver personalized rehabilitation programs, track patient progress, and adjust treatments in real-time; and Physiocourses, an e-learning library for healthcare professionals. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.…
Physitrack PLC - Transactions Under Share Buy-Back Programme
Physitrack (STO: PTRK) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 32 employees.
The shares were at 10.55 SEK on 20 November 2026, down 28.7% over 52 weeks. Its 52-week range is 7.360 SEK to 15.90 SEK: the price is 33.6% below the high and 43.3% above the low.
Its market capitalisation is 171.05M SEK.
Physitrack reports return on equity of -87.2%, an operating margin of 6.5% and revenue up 13.5% year over year.
Its debt exceeds its cash by 3.72M EUR, a debt-to-equity ratio of 0.39. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 19.69 SEK is 86.7% above the current price.